BPG is committed to discovery and dissemination of knowledge
JOURNAL HOME
Number of total visits
2732157
Number of visits today
240
Number of downloads
2002978
MEMBERSHIP
BPG JOURNALS
Cited by in F6Publishing
For: Yang Z, Ye X, Zhang Y, Huang Y, Chen J, Zeng Y, Chen J. ECRG4 acts as a tumor suppressor in nasopharyngeal carcinoma by suppressing the AKT/GSK3β/β-catenin signaling pathway. Cytotechnology. [DOI: 10.1007/s10616-022-00520-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Karati D, Shaoo KK, Mahadik K, Kumr D. Glycogen synthase kinase-3β inhibitors as a novel promising target in the treatment of cancer: Medicinal chemistry perspective. Results in Chemistry 2022;4:100532. [DOI: 10.1016/j.rechem.2022.100532] [Reference Citation Analysis]
Write to the Help Desk
© 2004-2023 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345